Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$7.03M Sell
237,864
-12,916
-5% -$370K 1.4% 13
2014
Q3
$7.03M Sell
250,780
-79,467
-24% -$2.23M 1.34% 13
2014
Q2
$9.3M Sell
330,247
-1,300
-0.4% -$37.1K 1.77% 6
2014
Q1
$10.1M Buy
331,547
+40,314
+14% +$1.2M 1.87% 6
2013
Q4
$8.46M Sell
291,233
-5,206
-2% -$152K 1.51% 10
2013
Q3
$8.08M Buy
296,439
+32,671
+12% +$889K 1.43% 11
2013
Q2
$7.01M Buy
+263,768
New +$7.29M 1.47% 9

Other funds holding PFE

Robert N. Shapiro's PFE Position: Q4 2014 in Review

Robert N. Shapiro reduced its Pfizer (PFE) stake by 5.2% in Q4 2014, selling an estimated $370K and leaving 237,864 shares worth $7.03M. The position accounts for 1.4% of the portfolio, ranked #13.

Robert N. Shapiro first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $10.1M in Q1 2014. 1,859 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Robert N. Shapiro held 237,864 shares of Pfizer worth $7.03M as of Q4 2014.
  • Robert N. Shapiro sold 12,916 Pfizer shares in Q4 2014, an estimated $370K.
  • Pfizer made up 1.4% of Robert N. Shapiro's portfolio in Q4 2014, its #13 holding.
  • Robert N. Shapiro first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Pfizer position peaked at $10.1M in Q1 2014.
  • 1,859 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.